INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 41 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $4,000 | -42.9% | 1,000 | 0.0% | 0.00% | -66.7% |
| Q3 2016 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|